STOCK TITAN

Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Outset Medical (Nasdaq: OM), a medical technology company focused on revolutionizing dialysis through innovative technology, has announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. The company's management will deliver a presentation on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), un'azienda di tecnologia medica focalizzata sulla rivoluzione della dialisi attraverso tecnologie innovative, ha annunciato la sua partecipazione alla 46ª Conferenza Globale Annuale sulla Sanità di Goldman Sachs. Il management dell'azienda terrà una presentazione mercoledì 11 giugno 2025 alle 11:20 ora orientale. Investitori e interessati potranno seguire la presentazione in diretta e accedere alla registrazione tramite il sito web delle relazioni con gli investitori all'indirizzo investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), una empresa de tecnología médica centrada en revolucionar la diálisis mediante tecnología innovadora, ha anunciado su participación en la 46ª Conferencia Global Anual de Salud de Goldman Sachs. La dirección de la empresa realizará una presentación el miércoles 11 de junio de 2025 a las 11:20 a.m., hora del Este. Los inversores y partes interesadas podrán acceder tanto a la presentación en vivo como a la retransmisión archivada a través del sitio web de relaciones con inversores de la empresa en investors.outsetmedical.com.
혁신적인 기술로 투석 분야를 혁신하는 의료기술 회사인 Outset Medical(Nasdaq: OM)은 골드만삭스 제46회 연례 글로벌 헬스케어 콘퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 11일 수요일 동부 시간 오전 11시 20분에 발표를 진행할 예정입니다. 투자자 및 관심 있는 분들은 회사 투자자 관계 웹사이트 investors.outsetmedical.com을 통해 생중계 및 녹화된 웹캐스트를 시청할 수 있습니다.
Outset Medical (Nasdaq : OM), une entreprise de technologie médicale axée sur la révolution de la dialyse grâce à des technologies innovantes, a annoncé sa participation à la 46e conférence mondiale annuelle sur la santé de Goldman Sachs. La direction de l'entreprise présentera une intervention le mercredi 11 juin 2025 à 11h20, heure de l'Est. Les investisseurs et les parties intéressées pourront accéder à la fois à la présentation en direct et à la rediffusion via le site web des relations investisseurs de l'entreprise à l'adresse investors.outsetmedical.com.
Outset Medical (Nasdaq: OM), ein Medizintechnologieunternehmen, das sich auf die Revolutionierung der Dialyse durch innovative Technologien spezialisiert hat, hat seine Teilnahme an der 46. jährlichen globalen Gesundheitskonferenz von Goldman Sachs angekündigt. Das Management des Unternehmens wird am Mittwoch, den 11. Juni 2025, um 11:20 Uhr Eastern Time eine Präsentation halten. Investoren und Interessierte können sowohl die Live-Präsentation als auch die archivierte Webcast-Aufzeichnung über die Investor-Relations-Webseite des Unternehmens unter investors.outsetmedical.com abrufen.
Positive
  • None.
Negative
  • None.

SAN JOSE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that management will present at the Goldman Sachs 46th annual Healthcare conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time.

A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com


FAQ

When is Outset Medical (OM) presenting at the Goldman Sachs Healthcare Conference 2025?

Outset Medical will present at the Goldman Sachs Healthcare Conference on Wednesday, June 11, 2025, at 11:20 a.m. Eastern time.

How can I watch Outset Medical's (OM) presentation at the Goldman Sachs Healthcare Conference?

The presentation can be accessed through a live and archived webcast on Outset Medical's investor relations website at investors.outsetmedical.com.

What does Outset Medical (OM) specialize in?

Outset Medical is a medical technology company that develops first-of-its-kind technology aimed at reducing the cost and complexity of dialysis.

Where can investors find Outset Medical's (OM) conference presentation materials?

Investors can access the presentation materials through the 'Investors' section of Outset Medical's website at investors.outsetmedical.com.
Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Stock Data

333.36M
16.41M
0.45%
18.84%
20.84%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SAN JOSE